Thanks for your constructive feedback. I understand their journey is different to DXB. I also noted that soarsentan is not FDA approved. What I try to mean was if DXB could be there where Travere today, there is a significant potential.
Also, one thing I want to mention without being rude, even the best if tthe best could get their DD wrong.
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-39
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $219.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 09.51am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
40.5¢ |
Change
0.000 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 40.5¢ | 40.0¢ | 280923 | ||
| Last updated 10.10am 30/05/2024 ? | |||||
| DXB (ASX) Chart |
Day chart unavailable